Development of a Vaccine against SARS-CoV-2 Based on the Receptor-Binding Domain Displayed on Virus-Like Particles

Development of a Vaccine against SARS-CoV-2 Based on the Receptor-Binding Domain Displayed on Virus-Like Particles

The ongoing coronavirus disease (COVID-19) pandemic is caused by a new coronavirus (severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2)) first reported in Wuhan City, China. From there, it has been rapidly spreading to many cities inside and outside China. Nowadays, more than 110 milli...

Full description

Bibliographic Details
Main Authors: Lisha Zha, Xinyue Chang, Hongxin Zhao, Mona O. Mohsen, Liang Hong, Yuhang Zhou, Hongquan Chen, Xuelan Liu, Jie Zhang, Dong Li, Ke Wu, Byron Martina, Junfeng Wang, Monique Vogel, Martin F. Bachmann
Format: Article
Language:English
Published: MDPI AG 2021-04-01
Series:Vaccines
Subjects:
COVID-19
vaccine
virus-like particle
CuMV<sub>TT</sub>–RBD
BLI
Online Access:https://www.mdpi.com/2076-393X/9/4/395

Internet

https://www.mdpi.com/2076-393X/9/4/395

Similar Items